Introduction
Selective expansion of gene-modified hematopoietic stem and progenitor cells in vitro and/or in vivo will be of key importance to the successful treatment of many hematologic disorders. It has been shown that ectopic expression of the homeobox protein HoxB4 leads to a selective expansion of murine hematopoietic stem cells in vivo. 1, 2 Notably, the animals did not develop any obvious abnormalities during the observation period, such as a myeloproliferative disease. However, due to the lack of appropriate reagents or coexpressed reporter proteins allowing single cell analysis, expression levels of the HoxB4 protein could not be monitored in vivo. Alterations in the expression levels of certain Hox genes have been clearly implicated in leukemia. 3 Thus, it seems reasonable that a 'therapeutic window' for HoxB4 levels has to be defined in hematopoetic stem and progenitor cells before its use can be proposed for human gene therapy.
Although reporter proteins coexpressed from the same vector have simplified the detection of transduced cells in the peripheral blood of reconstituted animals in vivo, conclusions on the amounts of the protein of interest, eg HoxB4, cannot be drawn when using conventional coexpression strategies. Until recently, either a second an indirect quantification of HoxB4 expression levels when inserting a reporter such as the enhanced green fluorescent protein (GFP) in the retroviral vector. Presence of the 2A sequence did not interfere with the correct subcellular localization of HoxB4 (nuclear) and GFP (cytoplasmic), nor with the titer of bicistronic vectors, and mediated functional longterm coexpression (at least 1 year) of GFP and HoxB4 after transplantation of transduced mouse bone marrow cells in mice. Gene Therapy (2001) 8, 811-817.
internal promoter 1,2,4,5 or a picornaviral internal ribosomal entry site (IRES) 6 was used for coexpression of HoxB4 and a reporter or a selectable marker from a retroviral vector. Unfortunately, none of these strategies ensures predictable concordant expression of both proteins: internal promoters are frequently down-regulated in retroviral vectors 7 and expression from the most commonly used IRES elements varies profoundly in different cell types, 8 probably reflecting the dependence on binding of cellular factors, many of which still need to be defined. 9 A possible solution is the expression of a fusion protein containing a self-processing moiety such as the 2A sequence of foot-and-mouth disease virus (FMDV). Its activity leads to a constant molar ratio of the separated proteins which is independent of the intracellular environment. In contrast to the self-cleaving proteinases encoded by the 2A region of the rhino-and enteroviral genome, 10, 11 the peptide encoded by the same region of FMDV does not posses proteolytic activity 12 nor is it toxic to eukaryotic cells. 13 Rather, it seems to be an esterase which modulates ribosomal translation at a glycyl-prolyl bond, 12 leading to separation of the growing polypeptide chain at its own C-terminus.
14 Because it only needs eukaryotic ribosomes to be active, 14 it is an attractive tool for in vivo coexpression strategies. It has been reported that the 2A sequence is biochemically functional in heterologous virus-based expression systems in vitro, [15] [16] [17] [18] but it still is unclear whether its presence perturbs subcellular distribution of the coexpressed proteins or if it can be used to coexpress a therapeutically interesting cDNA, such as the one of HoxB4, in hematopoietic cells in vivo.
This study was carried out to verify the potential of the 2A sequence for predictable coexpression of the nuclear located protein, HoxB4, together with a cytoplasmic protein. In this work, the enhanced green fluorescent protein (GFP) was used as the reporter because it allows a sensitive quantification of HoxB4 expression in single cells. In vectors designed for human gene therapy of inherited hematopoietic disorders, GFP may be replaced with a cDNA that has a therapeutic impact, without conferring a selective advantage per se. We show that, in the context investigated here, the 2A sequence is superior to an IRES derived from poliovirus (PV) or FMDV for coexpression of HoxB4 and a cytoplasmic protein (GFP). Furthermore, we demonstrate that it can be used for in vivo analysis of transduced hematopoietic cells.
Results
The IRES leads to a decrease in titers of the HoxB4 coexpression vector We developed retroviral vectors to coexpress the nuclearlocated human transcription factor HoxB4 1 with GFP, which itself does not show any preferential subcellular localization. The two genes were either fused directly, by the 2A peptide or linked by an IRES belonging to one of two different subgroups (genera) of the picornavirus family, poliovirus (an enterovirus) and FMDV (an aphtovirus) (Figure 1a ). To achieve optimal activity, the C-terminal six amino acids of the FMDV-virus protein 1D (=VP1) preceding 2A were included, leading to the expression of a 25 amino acid moiety. 13 Separation of the fusion protein resulted in a C-terminal extended GFP as well as the tagged HoxB4 protein plus one additional proline residue at its N-terminus (Figure 1b) . To ensure optimal translation initiation when utilizing the IRES element of FMDV, the HoxB4 cDNA was fused to the first 15 virus-encoded amino acids ensuring expression from the authentic viral initiation site. 19 In the case of the poliovirus IRES, the start codon was placed 22 nucleo- Pseudotyped vector particles were generated after cotransfection of Phoenix-ampho cells (G Nolan, Stanford) with a VSV-G expressing plasmid. Titers were determined on murine fibroblasts (see Materials and methods). Figure 2 shows the results of three independent transfection/titration experiments: all three monocistronic vectors, expressing only GFP or GFP fused to HoxB4 with or without the 2A protein showed comparable and high titers. In contrast, introduction of an IRES into the retroviral vectors caused a more than 10-fold decrease of titer. These reductions were unlikely to be due to variations in the transfection efficiencies because all transfected packaging cells showed comparable vector-RNA driven GFP expression, as determined by FACS analysis (data not shown). tem, cytoplasmic and nuclear extracts of transduced fibroblasts were prepared for immunodetection of GFP and HoxB4 proteins.
All vectors expressed the expected size of GFP. In contrast to the IRES-containing vectors, the GFP control vector ('GFP+30aa', Figure 4 ) still contained the entire multiple cloning site of pEGFPC1, accounting for the increased molecular weight of the detected protein.
Immunoblots confirmed the subcellular localization of GFP as observed by immunofluorescence (Figure 4 , upper panels: cytoplasmic GFP, nuclear GFP): after expression as a fusion protein with HoxB4 (GFP-HoxB4) it was only detected in trace amounts in the cytoplasm. Instead, it predominantly colocalized with HoxB4 in the nucleus. Cytoplasmic expression of GFP was restored when the 2A protein was included in the fusion protein (GFP-2A-HoxB4). Moreover, the amounts of expressed cytoplasmic GFP were comparable between the self-separating construct and the IRES-containing vectors. The extent of 2A-mediated separation was estimated by densitometry (upper right panel, lanes GFP-HoxB4 and GFP-2A-HoxB4). About 5-10% of the protein appeared to be refractory to the presence of 2A; this is in the range of the expected activity. 13 Interestingly, less HoxB4 was detected after expression Gene Therapy from the 2A-containing vector than after expression as a fusion with GFP ( Figure 4 , lower right panel, compare lanes 3 and 4). This lack of equimolarity of the N-and C-terminal products supports the model that the 2A protein is a modulator of translation and not a proteinase, consequently leading to a constant molar ratio of 8:1 of both proteins. 12 Furthermore, initiation of translation directed by an IRES led to a shorter form of HoxB4 than expected. Therefore, initiation of translation must have occurred more efficiently at the authentic start codon of HoxB4 in-frame 117 nucleotides downstream of the artificial flag-tag start codon. Reduced stringency of translation initiation controlled by an aphtoviraI IRES (to which the FMDV-IRES belongs) is well known, leading to translation starts from two different in-frame AUGs separated by 84 nucleotides. 21 Full-size translation products were indeed detected after prolonged exposure of the chemiluminescent blot. Their identity was confirmed after immunodetection with an antibody directed against the N-terminal flag-tag (data not shown).
HoxB4 and GFP are both functional after 2A-mediated protein separation Finally, we addressed whether the 2A coexpression strategy can be used to functionally express HoxB4 in vivo, thus leading to an expansion of gene-modified hematopoietic stem and progenitor cell pool as described.
1,2 In the case of coexpression of GFP and HoxB4, this expansion would be reflected by increased proportions of GFPpositive mature cells in the peripheral blood of reconstituted animals, thus enabling us to easily monitor protein expression following bone marrow transplantation. We therefore transduced prestimulated mononuclear bone marrow (BM) cells isolated from C57Bl/6J CD45.2 + mice with the control and coexpression vector (GFP and GFP-2A-HoxB4, respectively). To ensure comparable transduction efficiencies, cell-free supernatants were used with equivalent titers, as reported (see material and methods). was lympho-myeloid and the relative distribution of CD45.2/GFP-positive cells within the lineage-positive population did not differ between test and control animals (data not shown). This supported the conclusion that ectopic HoxB4 expression mediated by the 2A sequence leads to expansion of stem and progenitor cells without inducing transformation or alterations in differentiation, as previously observed with other coexpression strategies.
GFP and HoxB4 were detected immunologically after transfer of the proteins to nitrocellulose, as described. The positions of the molecular weight standard proteins are indicated on the left, identification of specific proteins is indicated by arrows on the right. To facilitate identification of the GFP-HoxB4 band, parts of the blot are shown in the lower panels after a shorter exposure time. Molecular weights of indicated proteins: GFP: 28 kD; GFP(+30 aa): 31 kD; GFP-2A: 30 kD; GFP-

1,2,6
Discussion
The success of gene therapeutic interventions in the hematopoietic compartment strictly depends on sufficient levels of corrected cells after transplantation of transduced stem cells. Recent clinical studies suggest an important role for the selective advantage of the modified cells in vivo, mediated either directly by the transduced gene 23 or indirectly by a gene conferring resistance to cytotoxic agents. 24 However, in the majority of patients suffering from inherited hematopoietic disorders, gene-corrected cells do not acquire a spontaneous selective advantage, and promoting engraftment of the transduced cells by preceding myeloablation or cytotoxic selection may be problematic. 25 Then, expression of a cDNA mediating stem cell expansion may offer a solution. HoxB4 is the only sequence known so far whose ectopic expression may lead to an expansion of hematopoietic stem cells without inducing transformation.
1,2 However, little is known about its therapeutic window in vivo. Therefore, tools need to be developed that allow a reliable expression analysis of HoxB4 or related sequences in hematopoietic cells. These tools may also be helpful for coexpression of HoxB4 with therapeutic cDNAs introduced to treat inherited hematopoietic disorders.
In this work, we have shown for the first time that the self-separating 2A moiety of FMDV can be used for functional coexpression of HoxB4 together with a fluorescent reporter protein in vivo, enabling us to easily monitor ongoing repopulation of the transduced cells in mice. The observed expansion of the transduced stem and precursor cells fits well with the results obtained with different HoxB4 expression vectors. 1, 2, 6 Since 2A function is not dependent on other cellular factors except eukaryotic ribosomes, 14 it can be presumed that translation of the linked proteins is independent of the cell type and differentiation status. This is a clear advantage over any other genetic strategy that may be used for coexpression of two cDNAs (IRES, internal promoters, or alternative splicing). It is well established, although mechanistically not yet understood, that the 2A moiety reduces expression of the subsequent protein to one eighth of the levels of the preceding, cap-proximally translated polypeptide sequence. 12 Although Humphries and colleagues also used the long terminal repeat of an identical retroviral vector (MSCV) for transcriptional control, monocistronic HoxB4 translation was initiated from the cap-proximal position.
1,2 Thus, our results indicate that expression of HoxB4 does not need to be that high to mediate expansion of transduced hematopoietic cells. The 2A-based coexpression strategy can therefore also be used to delineate the minimal dose of HoxB4 required for expansion while not leading to transformation or abnormalities in differentiation of gene-modified cells. This represents an important issue on the way to establishing the use of HoxB4 or related sequences in human gene therapy. In contrast to the 2A moiety, IRES elements, which are commonly used in retroviral vectors, are highly dependent on a plethora of cellular binding factors. 9 Thus, predictions about the efficiency with which a given IRES will drive expression of the controlled gene in terminally differentiated blood cell types after transplantation of transduced hematopoietic stem cells, cannot be made. Furthermore, we have observed that MSCV-based bicistronic vectors containing IRESes of two different genera of the picornavirus family, either from poliovirus (an enterovirus) or from FMDV (an aphtovirus), had significantly reduced titers as compared with that of monocistronic expression vectors. A possible explanation might be inefficient unwinding of the extensive secondary structures of the IRES during reverse transcription. Because high titers of the retroviral vectors and/or increased infectivity of the particles are required for Gene Therapy acceptable transduction rates into long-term repopulating cells, 26 IRES elements might not be optimal for application in gene therapy of hematopoietic stem cells. Even though high vector-titer producing packaging cells can in principle be obtained using IRES-containing retroviral vectors, 27 it usually involves a time-consuming selection procedure and the screening of many single cell clones. Our data indicate that the 2A protein offers the possibility to express HoxB4 and a second cDNA as a selfseparating polyprotein from one retroviral vector without negatively affecting retroviral vector titers.
Follow-up of mice after transplantation of bone marrow cells transduced with retroviral vectors expressing GFP-2A-HoxB4 or only GFP. Peripheral blood mononuclear cells were analyzed for CD45.2 and GFP expression by FACS analysis, as shown in representative dot blots obtained week 16 from a control mouse (a), a mouse reconstituted with BM cells transduced with monocistronic GFP (b) or the GFP-2A-HoxB4 vector (c). Numbers in the inset quadrant represent the percentages of live cells in the corresponding quadrant. Diagram (d) shows the proportion of GFP
In addition, we have extended previous reports on the use of the 2A sequence in viral gene vectors [16] [17] [18] by showing that retroviral vectors employing this self-separating moiety not only stably express both encoded proteins in vitro (Figure 4 ), but also mediate correct subcellular localization (nuclear versus cytoplasmic) of both polypeptides (Figure 3) . Nevertheless, when designing 2A-based expression vectors, the remaining 5% of unseparated translation products have to be taken into account to avoid a potential interference of the fusion protein with the intended function of the separated products. Although inclusion of the C-terminal 39 amino acids of capsid protein VP1 increases activity of the proteinase to 100%, 13 we preferred the use of a minimal sequence to reduce the likelihood of an immune response against vector containing cells or functional alterations of transgenes.
In summary, we have observed that 2A-mediated translational linkage of a cytoplasmic reporter and the homeobox protein HoxB4 led to functional coexpression in vivo. This work represents an important step towards elucidating the therapeutic window of HoxB4 or related proteins expressed for expansion of gene-modified stem cells, and contains interesting observations that may have a broader relevance for the construction of coexpression vectors in gene therapy.
Materials and methods
Construction of retroviral expression vectors MSCV-HoxB4neo 1 (kind gift of K Humphries, Terry Fox Laboratories, Vancouver, Canada) is a retroviral vector expressing human HoxB4 and neo R . It contains the transcriptional regulatory sequences derived from MESV. 28 This vector was cut with EcoRI and extended at its 5Ј end with an oligonucleotide coding for the FLAG-tag (sense: 5Ј-AATTCCCATATGGACTACAAAGACGAT-GACGATAAAAC-3Ј; antisense: 5Ј-AATTGTTTATCGTC ATCGTCTTTGTAGTCCATATGGG-3Ј).
An EcoRIBamHI fragment carrying the fusion cDNA was ligated into pEGFP-C1 (Clontech, Palo Alto, CA, USA) cut with the same enzymes. The resulting plasmid coded for a protein consisting of GFP, FLAG-tag and HoxB4. For the insertion of the FMDV 2A sequence and the IRES elements, the following steps were taken: the cDNA of the foot-and-mouth disease virus (FMDV) 2A region was amplified from pTG395 13 using the following oligonucleotides: sense: 5Ј-GCGCACCGGTGAAACAG-3Ј; antisense: 5Ј-CGAGGGCCCAGGGTTGG-3Ј); the IRES of FMDV (plasmid pSP449, kind gift of M Niepmann, University of Giessen, Germany) was liberated with EcoRI and SmaI (representing nt 11-506 of the FMDV-O 1 K genome) and the filled-in fragment ligated into the blunted EcoRI site between GFP and FLAG-HoxB4. The resulting expression cassette contained the first 15 aminoacids of the virus ensuring translation initiation from an optimized start codon. 19 A Klenow-blunted HindIIIXbaI fragment containing the IRES of poliovirus1 (Mahoney strain) (from plasmid LN⌬SHX (kind gift of Anke Richters, HPI Hamburg, Germany) nt 1-629 of the viral genome) was also ligated into the blunted EcoRI site between GFP and FLAG-HoxB4. In this case, the start codon was placed 22 nucleotides downstream of the insert, also ensuring correct translation initiation. 19 All of the cDNA cassettes were thereafter cut with NheI, blunted with Klenow-polymerase and released with BamHI. These fragments were ligated with a murine stem cell virus (MSCV)-based retroviral expression vector which was cut first with EcoRI, blunted with Klenow and recut with BamHI. Immunofluorescence and Western blots These were performed according to standard protocols. 29, 30 Briefly, cells were fixed in 3% (w/v) p-formaldehyde and 50 mm NH 4 Cl, permeabilized with 0.1% (v/v) Triton X-100 and incubated with rabbit polyclonal antiserum directed against GFP (Clontech) (dilution 1:200). Bound antibodies were detected with FITCcoupled goat anti-rabbit antiserum (Pharmingen, San Diego, CA, USA). To perform immunoblots, cytoplasmic and nuclear extracts were obtained from GFP-positive transduced cells, 31 which had previously been enriched by FACS. Twenty g protein of each sample was loaded and separated via 12% PAGE. After transfer to nitrocellulose, immunodetection was performed on the blotted proteins either with rabbit polyclonal anti-GFP antiserum (Clontech) or rabbit polyclonal antiserum directed against human HoxB4 (BAbCO, Richmond, CA, USA). Visualization of bound antibodies was performed using HRP-conjugated goat anti-rabbit antibodies with subsequent chemiluminescence reaction (ECL; Amersham Pharmacia Biotech, Freiburg, Germany). Animals C57BL/6J mice were kept in the animal facility of the Heinrich-Pette-Institute. Bone marrow cells were harvested from tibiae and femurs of 8-to 12-week-old male donor mice 4 days after intraperitoneal administration of 5-fluorouracil (Sigma, Deisenhofen, Germany) (150 mg/kg). Mononuclear cells were prestimulated in IMDM supplemented with 20% calf serum, 2 mm glutamine, 100 U/ml penicillin, 100 g/ml streptomycin and a conventional growth factor cocktail containing murine SCF (50 ng/ml), murine IL-3 (10 ng/ml) and human IL-6 (200 U/ml). Recombinant growth factors were from Strathmann Biotech (Hannover, Germany). Following 2 days of prestimulation, cell-free supernatants of retroviral particles were added. The multiplicity of infection (MOI) was 1 infectious particle per cell, as calculated from previous titration of supernatant aliquots on SC-1 fibroblasts (see above). Polybrene (Sigma) (4 g/ml) was supplemented, and cells were centrifuged for 1 h at 1100 g. This procedure was repeated three times within 48 h, with an interval of at least 8 h between individual rounds of transduction. One day after the final transduction, cells were transplanted by tail injection into five lethally irradiated (10 Gy) female CD45. -1 × 10 6 per reaction) were stained with phycoerythrin-conjugated monoclonal antibodies (Pharmingen, Hamburg, Germany) specific for CD45.2 or CD45.1 for 30 min at 4°C, washed and resuspended in 200 l of staining medium. Dead cells were excluded from the analysis by propidium iodide (Sigma) uptake. Samples were analyzed on a Becton Dickinson (Heidelberg, Germany) FACSCalibur (10 000-20 000 events), using CellQuest software. Control cells were obtained from nontransplanted C57Bl/6J mice.
